Standard Chemical & Pharmaceutical Co. Ltd. (TPE:1720)
60.50
+0.10 (0.17%)
Apr 2, 2025, 1:35 PM CST
TPE:1720 Revenue
In the year 2024, Standard Chemical & Pharmaceutical had annual revenue of 6.79B TWD with 8.81% growth. Standard Chemical & Pharmaceutical had revenue of 1.67B in the quarter ending December 31, 2024, with 5.08% growth.
Revenue
6.79B
Revenue Growth
+8.81%
P/S Ratio
1.59
Revenue / Employee
n/a
Employees
n/a
Market Cap
10.81B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 6.79B | 549.46M | 8.81% |
Dec 31, 2023 | 6.24B | 388.40M | 6.64% |
Dec 31, 2022 | 5.85B | 1.25B | 27.09% |
Dec 31, 2021 | 4.60B | 298.68M | 6.94% |
Dec 31, 2020 | 4.31B | 368.27M | 9.35% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
PharmaEssentia | 9.73B |
Caliway Biopharmaceuticals | 44.43M |
Bora Pharmaceuticals Co., LTD. | 19.25B |
Lotus Pharmaceutical | 18.58B |
Oneness Biotech | 117.93M |
Lumosa Therapeutics | 39.15M |
Pegavision | 6.82B |
Center Laboratories | 1.62B |